3 ms·
Avastin is an old, cheap, medication. It's useful for wet age-related macular degeneration, but it is not licenced for that. Drug companies ever-greened it by t
by DanBC 8y ago
Avastin is an old, cheap, medication. It's useful for wet age-related macular degeneration, but it is not licenced for that. Drug companies ever-greened it by tweaking it slightly and creating lucentis. Lucentis is almost identical to avastin in everything but price: it is very much more expensive.
Doctors are allowed to prescibe off-label.
The patent holders for Lucentis have tried very hard to prevent this off-label usage, going as far as suing the English NHS.
This case was won by the NHS (strictly, by twelve Clinical Commissioning Groups. You can think of those as regional branches of the NHS who commission services in their regions) so hopefully the NHS can save a lot of money and more people can get treatment for wet AMD.
I'm posting this to HN because Lucentis and Avantis have been mentioned before on HN, and it's a great example of unethical harmful behaviour from drug companies.